Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-05-16 Sale | 2023-05-18 6:19 pm | Akebia Therapeutics Inc. | AKBA | Spellman David A SVP, CFO and Treasurer | 63,567 | $1.068 | $67,890 | 446,483 (Direct) | View |
| 2023-03-01 Sale | 2023-03-03 08:00 am | Akebia Therapeutics Inc. | AKBA | Spellman David A SVP, CFO and Treasurer | 7,210 | $0.8775 | $6,327 | 510,050 (Direct) | View |
| 2023-02-27 Sale | 2023-03-01 4:05 pm | Akebia Therapeutics Inc. | AKBA | Spellman David A SVP, CFO and Treasurer | 7,539 | $0.8132 | $6,131 | 517,260 (Direct) | View |
| 2022-02-28 Sale | 2022-03-02 9:09 pm | Akebia Therapeutics Inc. | AKBA | Spellman David A SVP, CFO and Treasurer | 8,203 | $2.1564 | $17,689 | 353,599 (Direct) | View |
| 2021-04-01 Sale | 2021-04-01 8:34 pm | Akebia Therapeutics Inc. | AKBA | Spellman David A SVP, CFO and Treasurer | 790 | $3.4 | $2,686 | 76,802 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-01-31 Option Award | 2023-02-02 4:14 pm | N/A 2033-01-31 | Akebia Therapeutics Inc. | AKBA | Spellman David A SVP, CFO and Treasurer | 490,500 | $0 | 819,099 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-10 08:11 am | 2023-05-12 2032-06-08 | Akebia Therapeutics Inc. | AKBA | Spellman David A SVP, CFO and Treasurer | 200,000 | $0 | 528,599 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-02 9:09 pm | N/A 2032-02-28 | Akebia Therapeutics Inc. | AKBA | Spellman David A SVP, CFO and Treasurer | 285,000 | $0 | 353,599 (Direct) | View |
| 2021-09-30 Option Award | 2021-10-01 4:06 pm | N/A 2031-09-30 | Akebia Therapeutics Inc. | AKBA | Spellman David A SVP, CFO and Treasurer | 200,000 | $0 | 200,000 (Direct) | View |
| 2021-03-16 Option Award | 2021-03-18 7:19 pm | N/A N/A | Akebia Therapeutics Inc. | AKBA | Spellman David A SVP, CFO and Treasurer | 7,592 | $0 | 77,592 (Direct) | View |
| 2021-02-26 Option Award | 2021-03-02 4:05 pm | N/A 2031-02-26 | Akebia Therapeutics Inc. | AKBA | Spellman David A SVP, CFO and Treasurer | 190,000 | $0 | 190,000 (Direct) | View |
| 2020-06-30 Option Award | 2020-07-02 4:08 pm | N/A 2030-06-30 | Akebia Therapeutics Inc. | AKBA | Spellman David A SVP, CFO and Treasurer | 280,000 | $0 | 280,000 (Direct) | View |